Speaker Spotlight
Samantha Gillenwater, MD
Anas Hadeh, MD, ATSF, FCCP
Anas Hadeh, MD, ATSF, FCCP
Dr. Samantha Gillenwater is a pulmonary and critical care physician at Cleveland Clinic in Weston Florida, where she serves as Director of the Medical Intensive Care Unit. She earned her medical degree from Ross University School of Medicine and completed both her residency and fellowship training at Cleveland Clinic in Weston, Florida. D
Dr. Samantha Gillenwater is a pulmonary and critical care physician at Cleveland Clinic in Weston Florida, where she serves as Director of the Medical Intensive Care Unit. She earned her medical degree from Ross University School of Medicine and completed both her residency and fellowship training at Cleveland Clinic in Weston, Florida. Dr. Gillenwater has special interests in pulmonary hypertension, critical care medicine, and recovery after severe illness. She founded the Post-ICU Clinic to support patients transitioning from intensive care to long-term recovery. Her work focuses on compassionate, evidence-based care, multidisciplinary collaboration, and advancing outcomes for critically ill patients.
Anas Hadeh, MD, ATSF, FCCP
Anas Hadeh, MD, ATSF, FCCP
Anas Hadeh, MD, ATSF, FCCP
Anas Hadeh, MD, ATSF is a pulmonary, critical care, and sleep medicine physician at Cleveland Clinic Florida, where he serves as Program Director of the Pulmonary and Critical Care Medicine Fellowship. He is a clinician-educator dedicated to training and mentoring the next generation of physicians and has led fellowship education initiati
Anas Hadeh, MD, ATSF is a pulmonary, critical care, and sleep medicine physician at Cleveland Clinic Florida, where he serves as Program Director of the Pulmonary and Critical Care Medicine Fellowship. He is a clinician-educator dedicated to training and mentoring the next generation of physicians and has led fellowship education initiatives for more than a decade. Dr. Hadeh’s clinical and academic interests include asthma, COPD, bronchiectasis, nontuberculous mycobacterial (NTM) lung disease and sleep apnea. He co-directs the Bronchiectasis and NTM Center at Cleveland Clinic Florida, advancing multidisciplinary care, education, research, and national collaboration to improve patient outcomes.
-50a0029.png/:/cr=t:10.96%25,l:0%25,w:100%25,h:78.08%25/rs=w:365,h:365,cg:true)
JAMES KLINGER, MD
Anas Hadeh, MD, ATSF, FCCP
JAMES KLINGER, MD
Dr. James R Klinger, MD, FCCP, ATSF is a member of the Division of Pulmonary, Sleep and Critical Care of Medicine at Rhode Island Hospital and Professor of Medicine at the Albert Medical School of Brown University. He is an NIH-funded basic science investigator with extensive experience in basic science and clinical research in pulmonary
Dr. James R Klinger, MD, FCCP, ATSF is a member of the Division of Pulmonary, Sleep and Critical Care of Medicine at Rhode Island Hospital and Professor of Medicine at the Albert Medical School of Brown University. He is an NIH-funded basic science investigator with extensive experience in basic science and clinical research in pulmonary hypertension. He currently serves as the director of the Pulmonary Hypertension Association accredited Comprehensive Care Center for PAH at Rhode Island Hospital and is co-chair of the CHEST Guidelines Committee for Pharmacologic Therapy for Adult Patients with Pulmonary Arterial Hypertension.
Monica Kraft, MD
Anas Hadeh, MD, ATSF, FCCP
JAMES KLINGER, MD
Reynold Panettieri, Jr, MD
Reynold Panettieri, Jr, MD
Reynold Panettieri, Jr, MD
Reynold A. Panettieri, Jr, MD, is Professor of Medicine, Vice Chancellor for Translational Medicine and Science, and the Director of the Rutgers Institute for Translational Medicine and Science. He is principal investigator on several NIH-sponsored grants and industry-sponsored clinical studies, director of a program project grant examini
Reynold A. Panettieri, Jr, MD, is Professor of Medicine, Vice Chancellor for Translational Medicine and Science, and the Director of the Rutgers Institute for Translational Medicine and Science. He is principal investigator on several NIH-sponsored grants and industry-sponsored clinical studies, director of a program project grant examining novel approaches in modulating G protein-coupled receptor function, and is Principal Investigator of New Jersey’s CTSA Hub ‘New Jersey Alliance for Clinical and Translational Science’. He has authored over 500 peer-reviewed publications.
Dr. Panettieri manages the clinical care of asthma patients and is engaged in clinical investigations on management of asthma and COPD
Andrej petrov, MD
Reynold Panettieri, Jr, MD
Reynold Panettieri, Jr, MD
Dr. Andrej Petrov is a professor of medicine and Section Chief of Allergy in the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine at the University of Pittsburgh Medical Center. He is the Director of the Upper Airway Exercise Breathing Center, which focuses on the diagnosis and treatment of the upper and middle airway caus
Dr. Andrej Petrov is a professor of medicine and Section Chief of Allergy in the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine at the University of Pittsburgh Medical Center. He is the Director of the Upper Airway Exercise Breathing Center, which focuses on the diagnosis and treatment of the upper and middle airway causes of dyspnea. His research interests are focused on the interaction between the upper airway disorders and respiratory and allergic conditions.
Juan Salgado, MD
Reynold Panettieri, Jr, MD
Russell Settipane, MD
Dr. Juan C. Salgado is a transplant pulmonologist and intensivist with expertise in advanced lung
disease, extracorporeal life support (ECMO), and perioperative lung transplant critical care. He serves
as Medical Director of the Lung Transplant Program at Piedmont Healthcare, where he is leading the development of a comprehensive thoracic t
Dr. Juan C. Salgado is a transplant pulmonologist and intensivist with expertise in advanced lung
disease, extracorporeal life support (ECMO), and perioperative lung transplant critical care. He serves
as Medical Director of the Lung Transplant Program at Piedmont Healthcare, where he is leading the development of a comprehensive thoracic transplant and ECMO platform. Dr. Salgado completed
fellowship training in Pulmonary, Critical Care, and Pulmonary Transplant Medicine at the University of Pittsburgh Medical Center. His academic interests focus on the management of critically ill patients with end-stage lung disease, ECMO bridging strategies, and immediate postoperative lung transplant care.
He has authored multiple peer-reviewed publications and lectures internationally on ECMO, transplantation, and thoracic critical care.
Russell Settipane, MD
Reynold Panettieri, Jr, MD
Russell Settipane, MD
Russell Settipane, MD, co-director of the Allergy and Asthma Centers in East Providence, Rhode Island, is a Clinical Professor of Medicine at the Warren Alpert Medical School of Brown University. His allergy and immunology fellowship was completed at Scripps Clinic and Research Foundation in La Jolla, CA. He has participated in over 100 c
Russell Settipane, MD, co-director of the Allergy and Asthma Centers in East Providence, Rhode Island, is a Clinical Professor of Medicine at the Warren Alpert Medical School of Brown University. His allergy and immunology fellowship was completed at Scripps Clinic and Research Foundation in La Jolla, CA. He has participated in over 100 clinical trials and has authored more than 150 scientific articles, reviews, and book chapters in the field of allergy & immunology. Currently, he serves as President of the Rhode Island Society of Allergy, the American Association of Certified Allergists, and the Eastern Allergy Conference.
Gerard Silvestri, MD, MS, FCC
Gerard Silvestri, MD, MS, FCC
Gerard Silvestri, MD, MS, FCC
Dr. Silvestri is the Hillenbrand Distinguished University Professor of Thoracic Oncology at the Medical University of South Carolina. He completed his training in Pulmonary and Critical Care Medicine and health services research degrees at Dartmouth. He is an international expert in lung cancer. His research includes lung cancer screening
Dr. Silvestri is the Hillenbrand Distinguished University Professor of Thoracic Oncology at the Medical University of South Carolina. He completed his training in Pulmonary and Critical Care Medicine and health services research degrees at Dartmouth. He is an international expert in lung cancer. His research includes lung cancer screening, nodule evaluation, staging, biomarkers for disease risk and treatment, and disparities. Dr. Silvestri is a writer of the ACCP lung cancer guidelines. He has authored more than 300 scientific articles, book chapters and editorials. He is past president of ACCP and serves on the journal Chest editorial board. He serves on the steering committee of the American Cancer Society’s National Lung Cancer Roundtable. Dr. Silvestri was the recipient of the 2020 lifetime achievement award in Lung Cancer from the ATS. In 2022, Dr. Silvestri was named an ACCP Master Fellow.
David Zisman, MD, MS, FCCP
Gerard Silvestri, MD, MS, FCC
Gerard Silvestri, MD, MS, FCC
David A. Zisman, MD, MS, FCCP is Chair of the Department of Pulmonary and Critical Care Medicine at Weston Hospital, Cleveland Clinic Florida, and Director of the Interstitial Lung Disease Program and Pulmonary Fibrosis Foundation Care Center. He is internationally recognized for his expertise in interstitial lung disease, idiopathic pulm
David A. Zisman, MD, MS, FCCP is Chair of the Department of Pulmonary and Critical Care Medicine at Weston Hospital, Cleveland Clinic Florida, and Director of the Interstitial Lung Disease Program and Pulmonary Fibrosis Foundation Care Center. He is internationally recognized for his expertise in interstitial lung disease, idiopathic pulmonary fibrosis, and pulmonary hypertension associated with lung disease (PH-ILD). Dr. Zisman has held faculty appointments at the Mayo Clinic, University of Pennsylvania, UCLA, and USC, and has authored several high-impact peer-reviewed publications and numerous book chapters. He serves on national and international research and advisory committees advancing pulmonary fibrosis and PH-ILD.